- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 20-F Annual report (foreign)
- 2.22 First Amendment to Credit Agreement, Dated As of October 24, 2006
- 2.23 Second Amendment to Credit Agreement, Dated As of October 27, 2008
- 2.24 Guaranty, Dated As of December 23, 2008
- 2.26 First Amendment to Credit Agreement, Dated As of October 27, 2008
- 2.27 Guaranty, Dated As of December 23, 2008
- 4.1 Agreement and Plan of Merger, Dated As of January 22, 2008
- 8 Subsidiaries of the Registrant
- 10 Consent of Kesselman & Kesselman
- 12 Certification of the Chief Executive Officer Pursuant to Section 302
- 12 Certification of the Chief Financial Officer Pursuant to Section 302
- 13 Certification of the CEO and CFO Pursuant to 18 U.s.c. Section 1350
Exhibit 13
CERTIFICATION OF THE CEO AND CFO PURSUANT TO SECTION 906
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF
FINANCIAL OFFICER
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Teva Pharmaceutical Industries Limited (the “Company”) on Form 20-F for the period ended December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Shlomo Yanai, President and Chief Executive Officer of the Company, and Eyal Desheh, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: February 27, 2009
/s/ SHLOMO YANAI |
Shlomo Yanai President and Chief Executive Officer |
/s/ EYAL DESHEH |
Eyal Desheh Chief Financial Officer |